Short Interest in CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Grows By 152.1%

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the target of a large growth in short interest in January. As of January 15th, there was short interest totaling 2,816 shares, a growth of 152.1% from the December 31st total of 1,117 shares. Based on an average daily volume of 13,587 shares, the days-to-cover ratio is presently 0.2 days. Based on an average daily volume of 13,587 shares, the days-to-cover ratio is presently 0.2 days.

CSPC Pharmaceutical Group Stock Up 3.3%

CSPCY stock traded up C$0.17 during trading on Thursday, reaching C$5.25. 978 shares of the company were exchanged, compared to its average volume of 4,816. The stock’s 50 day moving average price is C$4.35 and its 200 day moving average price is C$4.62. CSPC Pharmaceutical Group has a 52-week low of C$2.20 and a 52-week high of C$5.83.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.